NEW YORK (TheStreet) -- Hewlett-Packard (HPQ), the computer and printer maker, said fiscal fourth-quarter earnings fell from a year earlier but still topped Wall Street's expectations.
HP said adjusted earnings per share fell 12% from last year to $1.17 per share. Adjusted net revenue for the quarter ended in October dropped 3% to $32.3 billion.
Analysts were expecting profit of $1.13 a share on sales of $32 billion.
Chief Financial Officer Catherine Lesjak said HP was "remaining cautious" about fiscal 2012, and HP forecast non-GAAP earnings of 83 cents a share for its fiscal first quarter ending in January. Wall Street's current consensus view is for a profit of $1.11 a share. For the full year, the Dow component sees non-GAAP earnings of at least $4 per share vs. the average analysts' estimate of $4.54 a share.
In premarket trading Tuesday, HP shares fell 1.8% to $26.37.Netflix (NFLX) is raising an additional $200 million in capital through the sale of zero coupon convertible notes. Technology Crossover Ventures will be buying the notes, and has the right to nominate one person Netflix's board. The stock fell 3.7% to $71.75 in premarket trading Tuesday.
Hormel Foods (HRL) said fiscal fourth-quarter profit fell 3%. The maker of Spam said net income fell to $117.3 million, or 43 cents a share, from $121.1 million, or 45 cents, last year. Analysts were expecting a profit of 42 cents a share. Sales rose 2% percent to $2.1 billion. Hormel provided an outlook for 2012 above analysts' expectations.
Brocade Communications (BRCD) blew past Wall Street's expectations in its fiscal fourth quarter. The networking equipment company reported adjusted earnings of $79 million, or 16 cents a share, for the three months ended Oct. 29. Revenue was $550 million, up 9% on a sequential basis but virtually flat from last year. . Analysts were calling for a profit of 10 cents a share in the latest quarter on revenue of $527.4 million.
Medtronic (MDT), the health care technology provider, is expected by analysts Tuesday to report earnings of 82 cents a share on revenue of $4.1 billion. Last week, Medtronic agreed to sell Physio-Control, an emergency medical response technology group, to private-equity firm Bain Capital for $487 million.
Campbell Soup (CPB), the soup maker, is expected by analysts Tuesday to report earnings of 79 cents a share on revenue of $2.2 billion.
Chico's (CHS), the women's retailer, is expected by analysts to post third-quarter earnings of 20 cents a share on revenue of $548.5 million. Analysts surveyed by Thomson Reuters expect same-store sales for the quarter to rise mor e than 5%.
Gilead Sciences (GILD) agreed on Monday to buy Pharmasset (VRUS) for $11 billion in cash and debt, vaulting Gilead into the lead to develop the next generation of all-oral hepatitis C therapies. The acquisition price of $137 a share was an 89% premium to Pharmasset's closing price Friday of $72.67. Pharmasset shares rose 84.6% Monday to close at $134.14. -- Written by Joseph Woelfel
>To contact the writer of this article, click here: Joseph Woelfel >To submit a news tip, send an email to: tips@thestreet.com.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV